Welcome to LookChem.com Sign In|Join Free

HENAN SUNLAKE ENTERPRISE CORPORATION

Free supplier Enterprise Certification

Free
supplier
9th
years
Home>>Products>>144060-53-7

Product Certification&
Enterprise Certification

More Detail

HENAN SUNLAKE ENTERPRISE CORPORATION

Country: China (Mainland)

Business Type:Trading Company

Ms.summer

Tel: +86-371- 86259723

Mr.William

Tel: 17734809689

Ms.lisa

Tel: 17734809689

Ms.Tina

Tel: 86-371-86259723

Ms.Ann

Tel: 17734809689

Ms.Helen

Tel: 17734809689

Mobile: 17734809689

Tel: +86-371- 86259723

Fax: +86-371- 86259723

Province/state: HENAN

City: ZHENGZHOU

Street: Mingmen International Center, NO.222 Dongming Road,Zhengzhou,Henan,China

MaxCard:


qq Contact Suppliers

144060-53-7

CAS NO.144060-53-7

  • FOB Price: USD: /Metric Ton Get Latest Price
  • Min.Order: 100 Kilogram
  • Payment Terms: L/C,D/A,D/P,T/T,Other
  • Available Specifications:

    1(10-100)Metric Ton1(10-100)Metric Ton

Contact Supplier

Product Details

Keywords

  • RARECHEM AH PB 0251
  • 144060-53-7
  • C16H16N2O3S

Quick Details

  • ProName: 144060-53-7
  • CasNo: 144060-53-7
  • Molecular Formula: C16H16N2O3S
  • Appearance: powder
  • Application: 144060-53-7
  • DeliveryTime: Within 3-7 days
  • PackAge: Depended
  • Port: China Main Port
  • ProductionCapacity: 300 Kilogram/Month
  • Purity: 99%
  • Storage: Refrigerator
  • Transportation: by air or by sea
  • LimitNum: 100 Kilogram
  • Valid Period: 6 month
  • Application: Multipurpose intermediate
  • Application: ISO/9001 Certificate

Superiority

Febuxostat Basic information
product description Anti-gout drug Drugs increasing the risk of gout Intermediate Application
Product Name: Febuxostat
Synonyms: FEBUXOSTAT;Tei-6720;2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid;2-[3-Cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylic acid;2-(3-Cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic Acid;2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic Acid;TMX 67;Febuxosta
CAS: 144060-53-7
MF: C16H16N2O3S
MW: 316.37
EINECS:  
Product Categories: Heterocycles;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;zjh;API;Febuxostat;TRILIPIX;Other APIs;eterocycles
Mol File: 144060-53-7.mol
Febuxostat Structure
 
Febuxostat Chemical Properties
mp  238-239°(dec.)
storage temp.  Refrigerator
CAS DataBase Reference 144060-53-7(CAS DataBase Reference)
 
Safety Information
MSDS Information
 
 
Febuxostat Usage And Synthesis
product description Febuxostat developed by Teijin is a new generation of xanthine oxidase inhibitor, for the treatment of high uric acid disease (gout) on clinical , the structure is completely different from xanthine oxidase inhibitor drug developed 40 years ago, it is a new and efficient non-purine selective inhibitor of xanthine oxidase. Xanthine oxidase is a key enzyme in the promotion of uric acid. Febuxostat reduces blood uric acid level in gout patients with hyperuricemia , clinical studies show that the product is safe and effective, this product is metabolized by the liver, it does not depend on renal excretion, so for moderate - severe liver and kidney dysfunction patients it is not necessary to reduce the dose. Dose is once 1 day, 40 mg or 80 mg once ,it is not recommended for the treatment of gout patients without hyperuricemia. 
In February 2009, the US Food and Drug Administration (FDA) approved febuxostat for long-term treatment of gout patients with hyperuricemia.
Anti-gout drug Gout is a heterogeneous group of diseases, hereditary or acquired due to uric acid excretion decreasing and purine metabolism. Because the body produces too much uric acid and renal clearance capacity decreases, uric acid accumulates in the body, leading to urate crystals deposited in the joints and organs. Therefore, it means the treatment of gout usually taken to be: promote uric acid excretion, and suppression of uric acid, and adopt appropriate measures to improve related symptoms. 
Uric acid formation is associated with purine metabolism, in the final step of purine metabolism, hypoxanthine becomes xanthine through the role of xanthine oxidoreductase (XOR) ,then further generate uric acid ,inhibiting activity of the enzyme can effectively reduce uric acid production. Febuxostat is currently the world's latest generation of non-purine selective inhibitor of xanthine oxidase, which acts highly selectively on the oxidase, then reduces uric acid synthesis, reduces uric acid levels, thus effectively treats ventilation diseases. 
30 years, Allopurinol is the only clinically used drugs to inhibit production of uric acid and is used as gold drugs widely in clinical treatment of gout, and achieves good results in the anti-gout treatment. Compared with allopurinol, febuxostat has obvious advantages:
(1) allopurinol only inhibit reduced XOR while febuxostat shows a significant inhibitory effect on oxidized and reduced XOR , so its role of reducing the uric acid is more powerful, long-lasting;
(2) Because allopurinol is a purine analog,it is inevitable affecting other purine and pyridine metabolic activity . Therefore, allopurinol treatment should be repeated large doses of the drugs to maintain a high level. This also leads to serious or even fatal adverse reactions due to the accumulation of the drug-induced. However, Febuxostat as non-purine XOR inhibitors, has better security.
The above information is edited by the Chemicalbook of Tian Ye.
Drugs increasing the risk of gout Diuretics: furosemide , hydrochlorothiazide ), metolazone 
Salicylic acid: such as aspirin (aspirin) 
niacin
Cyclosporine (CyclosporineNeoral)
L-dopa (Levodopa)
Intermediate 4-hydroxy thiobenzamide CAS No.:25984-63-8 Appearance: light green to white powder. 
2- (4-hydroxyphenyl) -4-methyl-thiazole-5-carboxylic acid ethyl ester CAS: 161797-99-5 Appearance: yellow powder. 
2- (3-aldehyde-4-hydroxyphenyl) -4-methyl-thiazole-5-carboxylic acid ethyl ester CAS No.:161798-01-2 Appearance: light yellow to yellow powder.
2- [3-aldehyde-4-isobutyloxyphenyl] -4-methyl-thiazole-5-carboxylic acid ethyl ester CAS No.:161798-03-4 Appearance: Light yellow to white powder.
2- [3-cyano-4-isobutoxy-phenyl] -4-methyl-thiazole-5-carboxylic acid ethyl ester CAS No.:160844-75-7 Appearance: white to white powder.
Application Treatment of high uric acid disease (gout)
Chemical Properties Crystalline Solid
Usage antihyperlipidemic
Usage Xanthine oxidase/xanthine dehydrogenase inhibitor. Used for treatment of hyperuricemia and chronic gout. 40-120 mg/day febuxostat was proven effective in lowering serum urate levels when administered to manage hyperuricemia in patients with gout.
Usage Febuxostat is primarily indicated in conditions like Gout, Hyperuricemia
 
 

 

 

 

 

 

Service we provide:

 

1. Mixed container, we can mix different items in one container.

2. Quality control, before shipment, free sample for test. after shipment,  keep sample for 3 years

3. Prompt shipment with professional documents

4. Packing as your request, with photo before shipment

 

 

 

 

 

 

 

 

 

Details

  • Exhibition in shanghai

 

 

We have clients throughout the world:

Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet your desire.

 

 

 

 

 

 

 

Our Laboratoy

 

 

We have our own independent lab test center:

This makes sure that our technology support is reliable and authoritative.All of self-owned fine chemicals are manufactured strictly in accordance with international standard.,and also has scientific cooperation with local colleges and institutes.

 

 

 

 

 

Our factory

 

 

High quality with competitive price:

We are manufacturer and can provide high quality products with factory price

 

 

 

 

 

 

Package  & Shipment

 

 

Fast and safe delivery:

Parcels can be sent out within 24 hours after payment. Tracking number is available

Secure and discreet shipment. You have various choices of transportation methods

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hot Product